See every side of every news story
Get Started
SubscribeLogin
Israel-Hamas Conflict
Tariffs
Natural Disasters
Social Media
Soccer
Donald Trump
Premier League
South America
Floods
Military
Instagram
Trade
US Politics
Published • loading... • Updated

Clinically relevant clot resolution via a thromboinflammation-on-a-chip

Summary by Nature
Thromboinflammation occurs in various diseases, leading to life-threatening microvascular occlusion with resulting end-organ failure1–4. Importantly, how microvascular thromboinflammation resolves remains poorly understood due to the small size-scale of microvasculature and the long duration (weeks to months) of this process. Here we introduce a hydrogel-based thromboinflammation-on-a-chip model with long-term culture capabilities to model micro…

3 Articles

All
Left
Center
1
Right
NatureNature
Center

Clinically relevant clot resolution via a thromboinflammation-on-a-chip

Thromboinflammation occurs in various diseases, leading to life-threatening microvascular occlusion with resulting end-organ failure1–4. Importantly, how microvascular thromboinflammation resolves remains poorly understood due to the small size-scale of microvasculature and the long duration (weeks to months) of this process. Here we introduce a hydrogel-based thromboinflammation-on-a-chip model with long-term culture capabilities to model micro…

·United Kingdom
Read Full Article
Interventional NewsInterventional News

VentiV Scientific mechanical thrombectomy system granted FDA approval - Interventional News

VentiV Scientific has announced the US Food and Drug Administration (FDA) clearance of VentiV mechanical thrombectomy system to remove blood clots from the peripheral vasculature including the new VentiV Pulse platform. “Electric pump-based thrombectomy systems can unexpectedly clog and/or remove 5–15ml per second of blood before removing blood clots,” said Dan Ryan, board of directors, VentiV Scientific.  “The Pulse is designed to instantly sta…

Read Full Article
Endovascular TodayEndovascular Today

VentiV Mechanical Thrombectomy System Cleared by FDA - Endovascular Today

April 1, 2025—VentiV Scientific recently announced the FDA clearance of the VentiV mechanical thrombectomy system for removal of blood clots in the peripheral vasculature. According to the company, the system includes the new VentiV Pulse platform. Pulse is designed to instantly start, stop, increase, and/or decrease thrombectomy force at the tip, decrease clogging inside the catheter, and reduce blood loss using any currently available aspirati…

Read Full Article
Think freely.Subscribe and get full access to Ground NewsSubscriptions start at $9.99/yearSubscribe

Bias Distribution

  • 100% of the sources are Center
100% Center
Factuality

To view factuality data please Upgrade to Premium

Ownership

To view ownership data please Upgrade to Vantage

Endovascular Today broke the news in on Tuesday, April 1, 2025.
Sources are mostly out of (0)

Similar News Topics

Nature

Nature

Science

Science

United States

United States

You have read out of your 5 free daily articles.

Join us as a member to unlock exclusive access to diverse content.

News
For You
SearchBlindspotLocal